JP2015518491A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518491A5
JP2015518491A5 JP2015510493A JP2015510493A JP2015518491A5 JP 2015518491 A5 JP2015518491 A5 JP 2015518491A5 JP 2015510493 A JP2015510493 A JP 2015510493A JP 2015510493 A JP2015510493 A JP 2015510493A JP 2015518491 A5 JP2015518491 A5 JP 2015518491A5
Authority
JP
Japan
Prior art keywords
use according
substituted
unsubstituted
alkyl
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015510493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518491A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/039562 external-priority patent/WO2013166449A2/en
Publication of JP2015518491A publication Critical patent/JP2015518491A/ja
Publication of JP2015518491A5 publication Critical patent/JP2015518491A5/ja
Pending legal-status Critical Current

Links

JP2015510493A 2012-05-04 2013-05-03 糖尿病性網膜症及び他の眼の疾患を治療するための方法 Pending JP2015518491A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261643058P 2012-05-04 2012-05-04
US201261643051P 2012-05-04 2012-05-04
US201261643178P 2012-05-04 2012-05-04
US61/643,051 2012-05-04
US61/643,178 2012-05-04
US61/643,058 2012-05-04
US201361781907P 2013-03-14 2013-03-14
US61/781,907 2013-03-14
PCT/US2013/039562 WO2013166449A2 (en) 2012-05-04 2013-05-03 Methods for the treatment of diabetic retinopathy and other ophthalmic diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017214372A Division JP2018024702A (ja) 2012-05-04 2017-11-07 糖尿病性網膜症及び他の眼の疾患を治療するための方法

Publications (2)

Publication Number Publication Date
JP2015518491A JP2015518491A (ja) 2015-07-02
JP2015518491A5 true JP2015518491A5 (https=) 2016-04-21

Family

ID=49515046

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015510493A Pending JP2015518491A (ja) 2012-05-04 2013-05-03 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2017214372A Pending JP2018024702A (ja) 2012-05-04 2017-11-07 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2019187273A Pending JP2020023535A (ja) 2012-05-04 2019-10-11 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2021024721A Pending JP2021075576A (ja) 2012-05-04 2021-02-18 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2023029073A Pending JP2023059991A (ja) 2012-05-04 2023-02-28 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2025017056A Pending JP2025069362A (ja) 2012-05-04 2025-02-04 糖尿病性網膜症及び他の眼の疾患を治療するための方法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2017214372A Pending JP2018024702A (ja) 2012-05-04 2017-11-07 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2019187273A Pending JP2020023535A (ja) 2012-05-04 2019-10-11 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2021024721A Pending JP2021075576A (ja) 2012-05-04 2021-02-18 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2023029073A Pending JP2023059991A (ja) 2012-05-04 2023-02-28 糖尿病性網膜症及び他の眼の疾患を治療するための方法
JP2025017056A Pending JP2025069362A (ja) 2012-05-04 2025-02-04 糖尿病性網膜症及び他の眼の疾患を治療するための方法

Country Status (18)

Country Link
US (4) US9957224B2 (https=)
EP (2) EP3741742A1 (https=)
JP (6) JP2015518491A (https=)
KR (1) KR20150013240A (https=)
CN (3) CN116850163A (https=)
AU (1) AU2013256029A1 (https=)
BR (1) BR112014027571B1 (https=)
CA (1) CA2872433C (https=)
EA (1) EA201492031A1 (https=)
ES (1) ES2792923T3 (https=)
HK (2) HK1203478A1 (https=)
IL (1) IL235446A0 (https=)
MX (2) MX2014013341A (https=)
PH (1) PH12014502449A1 (https=)
SG (1) SG11201407162SA (https=)
TW (1) TW201406707A (https=)
WO (1) WO2013166449A2 (https=)
ZA (1) ZA201408592B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103553945B (zh) 2007-10-05 2015-01-07 奥克塞拉有限公司 用于治疗疾病的烷氧基化合物
JP5860398B2 (ja) * 2009-07-02 2016-02-16 アキュセラ インコーポレイテッド 視覚サイクルモジュレーターの薬理
ES2813415T3 (es) 2011-08-10 2021-03-23 Lankenau Inst Medical Res Métodos y composiciones para el tratamiento de enfermedades autoinmunes e inflamatorias
EP2804605A4 (en) 2012-01-20 2015-07-08 Acucela Inc SUBSTITUTED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES
TW201406707A (zh) 2012-05-04 2014-02-16 Acucela Inc 用以治療糖尿病性視網膜病變及其他眼部疾病之方法
CA2903483A1 (en) * 2013-03-12 2014-10-09 Acucela Inc. Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
US10022270B2 (en) * 2013-03-14 2018-07-17 Optimedica Corporation Laser capsulovitreotomy
AU2015243261B2 (en) * 2014-04-10 2020-06-25 Lankenau Institute For Medical Research Methods and compositions for the treatment of ocular diseases and disorders
US10792374B2 (en) 2015-10-09 2020-10-06 Case Western Reserve University Compositions and methods for the delivery of nucleic acids
CA3054735A1 (en) 2017-02-27 2018-08-30 Case Western Reserve University Visual cycle modulators
CN111526779B (zh) * 2017-12-28 2023-07-11 株式会社尼康 图像处理方法、图像处理程序、图像处理装置、图像显示装置、以及图像显示方法
MX2018008165A (es) * 2018-06-29 2019-12-30 Centro De Retina Medica Y Quirurgica S C Sistema portátil para la identificación de casos potenciales de edema macular diabético mediante procesamiento de imagen e inteligencia artificial.
WO2020014074A1 (en) 2018-07-07 2020-01-16 Acucela Inc. Device to prevent retinal hypoxia
CN112740099B (zh) 2018-07-30 2024-05-14 奥克塞拉有限公司 用于延缓近视进展的电子接触透镜的光学设计
CN112888440A (zh) * 2018-10-16 2021-06-01 豪夫迈·罗氏有限公司 Akt抑制剂在眼科中的用途
CN112804999B (zh) * 2018-10-19 2024-03-15 美迪诺亚公司 通过异丁司特治疗眼科疾病/病症或损伤的方法
JPWO2020240867A1 (https=) * 2019-05-31 2020-12-03
EP3886946A1 (en) 2019-06-05 2021-10-06 Regeneron Pharmaceuticals, Inc. Devices and methods for precision dose delivery
CN121667930A (zh) 2019-07-31 2026-03-17 奥克塞拉有限公司 用于将图像投射到视网膜上的设备
US11733545B2 (en) 2019-09-16 2023-08-22 Acucela Inc. Assembly process for an electronic soft contact lens designed to inhibit progression of myopia
WO2021168481A1 (en) 2020-02-21 2021-08-26 Acucela Inc. Charging case for electronic contact lens
CN111617313B (zh) * 2020-04-29 2022-09-06 天津医科大学眼科医院 一种眼用线性凝胶在作为临床孔源性视网膜脱离药物方面中的应用
WO2021231684A1 (en) 2020-05-13 2021-11-18 Acucela Inc. Electro-switchable spectacles for myopia treatment
AU2021288457A1 (en) 2020-06-08 2023-01-05 Acucela Inc. Lens with asymmetric projection to treat astigmatism
CA3174148A1 (en) 2020-06-08 2021-12-16 Acucela Inc. Projection of defocused images on the peripheral retina to treat refractive error
KR20230020391A (ko) 2020-06-08 2023-02-10 어큐셀라 인코포레이티드 누진 굴절 이상을 치료하기 위해 주변 디포커스를 이용하는 디바이스 상의 스틱
US11281022B2 (en) 2020-06-10 2022-03-22 Acucela Inc. Apparatus and methods for the treatment of refractive error using active stimulation
US11209672B1 (en) 2021-04-06 2021-12-28 Acucela Inc. Supporting pillars for encapsulating a flexible PCB within a soft hydrogel contact lens
US11366341B1 (en) 2021-05-04 2022-06-21 Acucela Inc. Electronic case for electronic spectacles
AU2022278549A1 (en) * 2021-05-16 2023-12-07 Metanoia Bio Inc. Methods and compositions for treating ocular neovascular disease
WO2022255332A1 (ja) * 2021-06-03 2022-12-08 国立大学法人大阪大学 未熟児網膜症スクリーニング方法、スクリーニング装置及び学習済モデル
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device
US20240408056A1 (en) * 2023-06-12 2024-12-12 Synaptogenix, Inc. Methods for repairing nerve damage using pkc activating therapeutic agents

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022788D0 (en) 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
US20030181531A1 (en) * 2003-02-11 2003-09-25 David Sherris Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
JP2005511576A (ja) * 2001-11-09 2005-04-28 アイテック・ファーマシューティカルズ 眼球血管新生病を治療する方法
CA2601278C (en) * 2004-03-17 2014-06-10 Lars Michael Larsen Prevention of retinopathy by inhibition of the visual cycle
US8969415B2 (en) * 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
CA2681850C (en) 2007-04-20 2013-07-23 Acucela Inc. Styrenyl derivative compounds for treating ophthalmic diseases and disorders
RU2470910C9 (ru) 2007-06-29 2013-05-20 Акьюсела, Инк. Соединения, представляющие собой алкинилфенильные производные, для лечения офтальмических заболеваний и расстройств
CN103553945B (zh) 2007-10-05 2015-01-07 奥克塞拉有限公司 用于治疗疾病的烷氧基化合物
MY156662A (en) 2007-11-01 2016-03-15 Acucela Inc Amine derivative compounds for treating ophthalmic diseases and disorders
CA2736229C (en) 2008-09-05 2015-06-09 Acucela Inc. Sulfur-linked compounds for treating opthalmic diseases and disorders
JP5773877B2 (ja) * 2008-10-22 2015-09-02 アキュセラ インコーポレイテッド 眼の疾患及び障害を治療する化合物
JP5860398B2 (ja) * 2009-07-02 2016-02-16 アキュセラ インコーポレイテッド 視覚サイクルモジュレーターの薬理
TW201406707A (zh) 2012-05-04 2014-02-16 Acucela Inc 用以治療糖尿病性視網膜病變及其他眼部疾病之方法

Similar Documents

Publication Publication Date Title
JP2015518491A5 (https=)
JP2016515560A5 (https=)
JP2013510124A5 (https=)
JP2010524932A5 (https=)
JP2014511892A5 (https=)
JP2016506960A5 (https=)
JP2016503797A5 (https=)
JP2019509276A5 (https=)
JP2014501766A5 (https=)
JP2015520140A5 (https=)
JP2018524390A5 (https=)
JP2014511891A5 (https=)
JP2013508279A5 (https=)
JP2013510123A5 (https=)
JP2013512277A5 (https=)
JP2016530259A5 (https=)
JP2016505637A5 (https=)
RU2018114518A (ru) Новые бициклические соединения в качестве двойных ингибиторов аутотаксина (atx)/карбоангидразы (ca)
JP2014523851A5 (https=)
JP2019510034A5 (https=)
JP2015504081A5 (https=)
JP2014516033A5 (https=)
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
JP2015516427A5 (https=)
JP2018501215A5 (https=)